Skip to main content
Top
Published in: Diabetologia 11/2011

01-11-2011 | Article

A diet high in fatty fish, bilberries and wholegrain products improves markers of endothelial function and inflammation in individuals with impaired glucose metabolism in a randomised controlled trial: The Sysdimet study

Authors: V. D. F. de Mello, U. Schwab, M. Kolehmainen, W. Koenig, M. Siloaho, K. Poutanen, H. Mykkänen, M. Uusitupa

Published in: Diabetologia | Issue 11/2011

Login to get access

Abstract

Aims/hypothesis

Low-grade inflammation and endothelial dysfunction may play a role in the pathogenesis of type 2 diabetes and cardiovascular disease. We evaluated whether a diet high in fatty fish, bilberries and wholegrain products (Healthy Diet) improves biomarkers reflecting inflammation and endothelial dysfunction in individuals with impaired glucose metabolism.

Methods

We recruited individuals with impaired glucose metabolism and features of the metabolic syndrome into a 12 week, parallel design, dietary intervention trial conducted at the Department of Clinical Nutrition, University of Eastern Finland (Kuopio, Finland). Randomisation was performed by matching according to sex and medians of age, BMI and fasting plasma glucose of the study population at screening. The primary endpoint in the present study was the change in plasma inflammatory markers and the measurements were performed blinded to group assignment. High-sensitivity (hs) C-reactive protein (CRP) and E-selectin responses were also analysed separately in participants not using statins (n = 76).

Results

Altogether, 131 individuals were assigned to either the Healthy Diet (n = 44), a whole-grain-enriched diet (WGED) (n = 42) or a control (n = 45) diet, and 104 participants (mean ± SD: age 59 ± 7 years; BMI 31.1 ± 3.5 kg/m2) who had completed the study, were analysed (Healthy Diet n = 36, WGED n = 34 and control diet n = 34). Plasma E-selectin decreased only in the Healthy Diet group. This occurred in all group participants (p < 0.05) and also after excluding participants using statins (p < 0.05). Plasma hsCRP levels decreased in the Healthy Diet (median −17%, p < 0.05) and WGED (median −27%, p < 0.01) groups in participants not using statins. Controlling for confounding factors, including BMI or insulin sensitivity, did not alter the results. A greater increase in plasma concentration of very-long-chain n-3 fatty acids and in the intake of fibre during the study was associated with a greater decrease in plasma E-selectin (p < 0.05). The intake of test breads consumed during the Healthy Diet and WGED interventions was inversely associated with the change in hsCRP levels (p < 0.001).

Conclusions/interpretation

Our results suggest that the combined effect of fatty fish, bilberries and wholegrain products may improve endothelial dysfunction and inflammation in overweight and obese individuals at high risk of developing diabetes.

Trial registration:

ClinicalTrials.gov NCT00573781

Funding:

The study was funded by the Academy of Finland (117844 and 118590 [to M. Uusitupa]; 131460 [to K. Poutanen]; 130469 [to H. Mykkänen] and 131593 [to V. D. F. de Mello]); the Kuopio University Hospital (5106, 5168, 5254 [to M. Uusitupa]); the Finnish Diabetes Research Foundation; the Sigrid Juselius Foundation; the Nordic Centre of Excellence on ‘Systems biology in controlled dietary interventions and cohort studies’ (SYSDIET; 070014); and the European Commission in the Communities 6th Framework Programme, Project HEALTHGRAIN (FOOD-CT-2005-514008).
Appendix
Available only for authorised users
Literature
1.
go back to reference Genuth S, Alberti KG, Bennett P et al (2003) Follow-up report on the diagnosis of diabetes mellitus. Diabetes Care 26:3160–3167PubMedCrossRef Genuth S, Alberti KG, Bennett P et al (2003) Follow-up report on the diagnosis of diabetes mellitus. Diabetes Care 26:3160–3167PubMedCrossRef
3.
go back to reference Emerging Risk Factors Collaboration, Kaptoge S, Di Angelantonio E, Lowe G et al (2010) C-reactive protein concentration and risk of coronary heart disease, stroke, and mortality: an individual participant meta-analysis. Lancet 375:132–140PubMedCrossRef Emerging Risk Factors Collaboration, Kaptoge S, Di Angelantonio E, Lowe G et al (2010) C-reactive protein concentration and risk of coronary heart disease, stroke, and mortality: an individual participant meta-analysis. Lancet 375:132–140PubMedCrossRef
4.
go back to reference Pradhan AD, Manson JE, Rifai N, Buring JE, Ridker PM (2001) C-reactive protein, interleukin 6, and risk of developing type 2 diabetes mellitus. JAMA 286:327–334PubMedCrossRef Pradhan AD, Manson JE, Rifai N, Buring JE, Ridker PM (2001) C-reactive protein, interleukin 6, and risk of developing type 2 diabetes mellitus. JAMA 286:327–334PubMedCrossRef
5.
go back to reference Laaksonen DE, Niskanen L, Nyyssonen K et al (2004) C-reactive protein and the development of the metabolic syndrome and diabetes in middle-aged men. Diabetologia 47:1403–1410PubMedCrossRef Laaksonen DE, Niskanen L, Nyyssonen K et al (2004) C-reactive protein and the development of the metabolic syndrome and diabetes in middle-aged men. Diabetologia 47:1403–1410PubMedCrossRef
6.
go back to reference Meigs JB, O'Donnell CJ, Tofler GH et al (2006) Hemostatic markers of endothelial dysfunction and risk of incident type 2 diabetes: the Framingham Offspring Study. Diabetes 55:530–537PubMedCrossRef Meigs JB, O'Donnell CJ, Tofler GH et al (2006) Hemostatic markers of endothelial dysfunction and risk of incident type 2 diabetes: the Framingham Offspring Study. Diabetes 55:530–537PubMedCrossRef
7.
go back to reference Hu FB, van Dam RM, Liu S (2001) Diet and risk of type II diabetes: the role of types of fat and carbohydrate. Diabetologia 44:805–817PubMedCrossRef Hu FB, van Dam RM, Liu S (2001) Diet and risk of type II diabetes: the role of types of fat and carbohydrate. Diabetologia 44:805–817PubMedCrossRef
8.
go back to reference Lindström J, Peltonen M, Eriksson JG et al (2006) High-fibre, low-fat diet predicts long-term weight loss and decreased type 2 diabetes risk: the Finnish Diabetes Prevention Study. Diabetologia 49:912–920PubMedCrossRef Lindström J, Peltonen M, Eriksson JG et al (2006) High-fibre, low-fat diet predicts long-term weight loss and decreased type 2 diabetes risk: the Finnish Diabetes Prevention Study. Diabetologia 49:912–920PubMedCrossRef
9.
go back to reference Sahyoun NR, Jacques PF, Zhang XL, Juan W, McKeown NM (2006) Whole-grain intake is inversely associated with the metabolic syndrome and mortality in older adults. Am J Clin Nutr 83:124–131PubMed Sahyoun NR, Jacques PF, Zhang XL, Juan W, McKeown NM (2006) Whole-grain intake is inversely associated with the metabolic syndrome and mortality in older adults. Am J Clin Nutr 83:124–131PubMed
10.
go back to reference Mellen PB, Walsh TF, Herrington DM (2008) Whole grain intake and cardiovascular disease: a meta-analysis. Nutr Metab Cardiovasc Dis 18:283–290PubMedCrossRef Mellen PB, Walsh TF, Herrington DM (2008) Whole grain intake and cardiovascular disease: a meta-analysis. Nutr Metab Cardiovasc Dis 18:283–290PubMedCrossRef
11.
12.
go back to reference Jensen MK, Koh-Banerjee P, Franz M, Sampson L, Gronbaek M, Rimm EB (2006) Whole grains, bran, and germ in relation to homocysteine and markers of glycemic control, lipids, and inflammation 1. Am J Clin Nutr 83:275–283PubMed Jensen MK, Koh-Banerjee P, Franz M, Sampson L, Gronbaek M, Rimm EB (2006) Whole grains, bran, and germ in relation to homocysteine and markers of glycemic control, lipids, and inflammation 1. Am J Clin Nutr 83:275–283PubMed
13.
go back to reference Masters RC, Liese AD, Haffner SM, Wagenknecht LE, Hanley AJ (2010) Whole and refined grain intakes are related to inflammatory protein concentrations in human plasma. J Nutr 140:587–594PubMedCrossRef Masters RC, Liese AD, Haffner SM, Wagenknecht LE, Hanley AJ (2010) Whole and refined grain intakes are related to inflammatory protein concentrations in human plasma. J Nutr 140:587–594PubMedCrossRef
14.
go back to reference Brownlee IA, Moore C, Chatfield M et al (2010) Markers of cardiovascular risk are not changed by increased whole-grain intake: the WHOLEheart study, a randomised, controlled dietary intervention. Br J Nutr 104:125–134PubMedCrossRef Brownlee IA, Moore C, Chatfield M et al (2010) Markers of cardiovascular risk are not changed by increased whole-grain intake: the WHOLEheart study, a randomised, controlled dietary intervention. Br J Nutr 104:125–134PubMedCrossRef
15.
go back to reference Wall R, Ross RP, Fitzgerald GF, Stanton C (2010) Fatty acids from fish: the anti-inflammatory potential of long-chain omega-3 fatty acids. Nutr Rev 68:280–289PubMedCrossRef Wall R, Ross RP, Fitzgerald GF, Stanton C (2010) Fatty acids from fish: the anti-inflammatory potential of long-chain omega-3 fatty acids. Nutr Rev 68:280–289PubMedCrossRef
16.
go back to reference Smith KM, Barraj LM, Kantor M, Sahyoun NR (2009) Relationship between fish intake, n-3 fatty acids, mercury and risk markers of CHD (National Health and Nutrition Examination Survey 1999–2002). Public Health Nutr 12:1261–1269PubMedCrossRef Smith KM, Barraj LM, Kantor M, Sahyoun NR (2009) Relationship between fish intake, n-3 fatty acids, mercury and risk markers of CHD (National Health and Nutrition Examination Survey 1999–2002). Public Health Nutr 12:1261–1269PubMedCrossRef
17.
go back to reference Basu A, Rhone M, Lyons TJ (2010) Berries: emerging impact on cardiovascular health. Nutr Rev 68:168–177PubMedCrossRef Basu A, Rhone M, Lyons TJ (2010) Berries: emerging impact on cardiovascular health. Nutr Rev 68:168–177PubMedCrossRef
18.
go back to reference Lappi J, Selinheimo E, Schwab U et al (2010) Sourdough fermentation of wholemeal wheat bread increases solubility of arabinoxylan and protein and decreases postprandial glucose and insulin responses. J Cereal Sci 51:152–158CrossRef Lappi J, Selinheimo E, Schwab U et al (2010) Sourdough fermentation of wholemeal wheat bread increases solubility of arabinoxylan and protein and decreases postprandial glucose and insulin responses. J Cereal Sci 51:152–158CrossRef
19.
go back to reference Juntunen KS, Laaksonen DE, Autio K et al (2003) Structural differences between rye and wheat breads but not total fiber content may explain the lower postprandial insulin response to rye bread. Am J Clin Nutr 78:957–964PubMed Juntunen KS, Laaksonen DE, Autio K et al (2003) Structural differences between rye and wheat breads but not total fiber content may explain the lower postprandial insulin response to rye bread. Am J Clin Nutr 78:957–964PubMed
20.
go back to reference Juntunen KS, Laaksonen DE, Poutanen KS, Niskanen LK, Mykkanen HM (2003) High-fiber rye bread and insulin secretion and sensitivity in healthy postmenopausal women. Am J Clin Nutr 77:385–391PubMed Juntunen KS, Laaksonen DE, Poutanen KS, Niskanen LK, Mykkanen HM (2003) High-fiber rye bread and insulin secretion and sensitivity in healthy postmenopausal women. Am J Clin Nutr 77:385–391PubMed
21.
go back to reference Lankinen M, Schwab US, Kolehmainen M et al. (2011) Whole grain products, fish and bilberries alter glucose and lipid metabolism in a randomized, controlled trial: the Sysdimet Study. PLoS ONE (in press) Lankinen M, Schwab US, Kolehmainen M et al. (2011) Whole grain products, fish and bilberries alter glucose and lipid metabolism in a randomized, controlled trial: the Sysdimet Study. PLoS ONE (in press)
22.
go back to reference National Institute for Health and Welfare, Nutrition Unit (2010) Fineli: Finnish food composition database. Release 11. National Institute for Health and Welfare, Helsinki National Institute for Health and Welfare, Nutrition Unit (2010) Fineli: Finnish food composition database. Release 11. National Institute for Health and Welfare, Helsinki
23.
go back to reference Ridker PM, Danielson E, Fonseca FA et al (2009) Reduction in C-reactive protein and LDL cholesterol and cardiovascular event rates after initiation of rosuvastatin: a prospective study of the JUPITER trial. Lancet 373:1175–1182PubMedCrossRef Ridker PM, Danielson E, Fonseca FA et al (2009) Reduction in C-reactive protein and LDL cholesterol and cardiovascular event rates after initiation of rosuvastatin: a prospective study of the JUPITER trial. Lancet 373:1175–1182PubMedCrossRef
24.
go back to reference Meigs JB, Hu FB, Rifai N, Manson JE (2004) Biomarkers of endothelial dysfunction and risk of type 2 diabetes mellitus. JAMA 291:1978–1986PubMedCrossRef Meigs JB, Hu FB, Rifai N, Manson JE (2004) Biomarkers of endothelial dysfunction and risk of type 2 diabetes mellitus. JAMA 291:1978–1986PubMedCrossRef
25.
go back to reference Hwang SJ, Ballantyne CM, Sharrett AR et al (1997) Circulating adhesion molecules VCAM-1, ICAM-1, and E-selectin in carotid atherosclerosis and incident coronary heart disease cases: the Atherosclerosis Risk In Communities (ARIC) study. Circulation 96:4219–4225PubMed Hwang SJ, Ballantyne CM, Sharrett AR et al (1997) Circulating adhesion molecules VCAM-1, ICAM-1, and E-selectin in carotid atherosclerosis and incident coronary heart disease cases: the Atherosclerosis Risk In Communities (ARIC) study. Circulation 96:4219–4225PubMed
26.
go back to reference Erkkilä A, de Mello VDF, Risérus U, Laaksonen DE (2008) Dietary fatty acids and cardiovascular disease: an epidemiological approach. Prog Lipid Res 47:172–187PubMedCrossRef Erkkilä A, de Mello VDF, Risérus U, Laaksonen DE (2008) Dietary fatty acids and cardiovascular disease: an epidemiological approach. Prog Lipid Res 47:172–187PubMedCrossRef
27.
go back to reference Adkins Y, Kelley DS (2010) Mechanisms underlying the cardioprotective effects of omega-3 polyunsaturated fatty acids. J Nutr Biochem 21:781–792PubMedCrossRef Adkins Y, Kelley DS (2010) Mechanisms underlying the cardioprotective effects of omega-3 polyunsaturated fatty acids. J Nutr Biochem 21:781–792PubMedCrossRef
28.
go back to reference Thies F, Miles EA, Nebe-von-Caron G et al (2001) Influence of dietary supplementation with long-chain n-3 or n-6 polyunsaturated fatty acids on blood inflammatory cell populations and functions and on plasma soluble adhesion molecules in healthy adults. Lipids 36:1183–1193PubMedCrossRef Thies F, Miles EA, Nebe-von-Caron G et al (2001) Influence of dietary supplementation with long-chain n-3 or n-6 polyunsaturated fatty acids on blood inflammatory cell populations and functions and on plasma soluble adhesion molecules in healthy adults. Lipids 36:1183–1193PubMedCrossRef
29.
go back to reference Lopez-Garcia E, Schulze MB, Fung TT et al (2004) Major dietary patterns are related to plasma concentrations of markers of inflammation and endothelial dysfunction. Am J Clin Nutr 80:1029–1035PubMed Lopez-Garcia E, Schulze MB, Fung TT et al (2004) Major dietary patterns are related to plasma concentrations of markers of inflammation and endothelial dysfunction. Am J Clin Nutr 80:1029–1035PubMed
30.
go back to reference Määttä-Riihinen KR, Kamal-Eldin A, Mattila PH, Gonzalez-Paramás AM, Törrönen AR (2004) Distribution and contents of phenolic compounds in eighteen Scandinavian berry species. J Agric Food Chem 52:4477–4486PubMedCrossRef Määttä-Riihinen KR, Kamal-Eldin A, Mattila PH, Gonzalez-Paramás AM, Törrönen AR (2004) Distribution and contents of phenolic compounds in eighteen Scandinavian berry species. J Agric Food Chem 52:4477–4486PubMedCrossRef
31.
go back to reference Määttä-Riihinen KR, Kähkönen MP, Törrönen AR, Heinonen IM (2005) Catechins and procyanidins in berries of vaccinium species and their antioxidant activity. J Agric Food Chem 53:8485–8491PubMedCrossRef Määttä-Riihinen KR, Kähkönen MP, Törrönen AR, Heinonen IM (2005) Catechins and procyanidins in berries of vaccinium species and their antioxidant activity. J Agric Food Chem 53:8485–8491PubMedCrossRef
32.
go back to reference Münzel T, Gori T, Bruno RM, Taddei S (2010) Is oxidative stress a therapeutic target in cardiovascular disease? Eur Heart J 31:2741–2748PubMedCrossRef Münzel T, Gori T, Bruno RM, Taddei S (2010) Is oxidative stress a therapeutic target in cardiovascular disease? Eur Heart J 31:2741–2748PubMedCrossRef
33.
go back to reference Egert S, Stehle P (2011) Impact of n-3 fatty acids on endothelial function: results from human interventions studies. Curr Opin Clin Nutr Metab Care 14:121–131PubMedCrossRef Egert S, Stehle P (2011) Impact of n-3 fatty acids on endothelial function: results from human interventions studies. Curr Opin Clin Nutr Metab Care 14:121–131PubMedCrossRef
34.
go back to reference Myhrstad MC, Retterstol K, Telle-Hansen VH et al (2011) Effect of marine n-3 fatty acids on circulating inflammatory markers in healthy subjects and subjects with cardiovascular risk factors. Inflamm Res 60:309–319PubMedCrossRef Myhrstad MC, Retterstol K, Telle-Hansen VH et al (2011) Effect of marine n-3 fatty acids on circulating inflammatory markers in healthy subjects and subjects with cardiovascular risk factors. Inflamm Res 60:309–319PubMedCrossRef
35.
go back to reference Salas-Salvadó J, Garcia-Arellano A, Estruch R et al (2008) Components of the Mediterranean-type food pattern and serum inflammatory markers among patients at high risk for cardiovascular disease. Eur J Clin Nutr 62:651–659PubMedCrossRef Salas-Salvadó J, Garcia-Arellano A, Estruch R et al (2008) Components of the Mediterranean-type food pattern and serum inflammatory markers among patients at high risk for cardiovascular disease. Eur J Clin Nutr 62:651–659PubMedCrossRef
36.
go back to reference Salas-Salvadó J, Bullo M, Babio N et al (2011) Reduction in the incidence of type 2 diabetes with the Mediterranean diet: results of the PREDIMED-Reus nutrition intervention randomized trial. Diabetes Care 34:14–19PubMedCrossRef Salas-Salvadó J, Bullo M, Babio N et al (2011) Reduction in the incidence of type 2 diabetes with the Mediterranean diet: results of the PREDIMED-Reus nutrition intervention randomized trial. Diabetes Care 34:14–19PubMedCrossRef
37.
go back to reference Tsitouras PD, Gucciardo F, Salbe AD, Heward C, Harman SM (2008) High omega-3 fat intake improves insulin sensitivity and reduces CRP and IL6, but does not affect other endocrine axes in healthy older adults. Horm Metab Res 40:199–205PubMedCrossRef Tsitouras PD, Gucciardo F, Salbe AD, Heward C, Harman SM (2008) High omega-3 fat intake improves insulin sensitivity and reduces CRP and IL6, but does not affect other endocrine axes in healthy older adults. Horm Metab Res 40:199–205PubMedCrossRef
38.
go back to reference Madsen T, Christensen JH, Blom M, Schmidt EB (2003) The effect of dietary n-3 fatty acids on serum concentrations of C-reactive protein: a dose-response study. Br J Nutr 89:517–522PubMedCrossRef Madsen T, Christensen JH, Blom M, Schmidt EB (2003) The effect of dietary n-3 fatty acids on serum concentrations of C-reactive protein: a dose-response study. Br J Nutr 89:517–522PubMedCrossRef
39.
go back to reference Damsgaard CT, Frokiaer H, Andersen AD, Lauritzen L (2008) Fish oil in combination with high or low intakes of linoleic acid lowers plasma triacylglycerols but does not affect other cardiovascular risk markers in healthy men. J Nutr 138:1061–1066PubMed Damsgaard CT, Frokiaer H, Andersen AD, Lauritzen L (2008) Fish oil in combination with high or low intakes of linoleic acid lowers plasma triacylglycerols but does not affect other cardiovascular risk markers in healthy men. J Nutr 138:1061–1066PubMed
40.
go back to reference Ludwig DS (2002) The glycemic index: physiological mechanisms relating to obesity, diabetes, and cardiovascular disease. JAMA 287:2414–2423PubMedCrossRef Ludwig DS (2002) The glycemic index: physiological mechanisms relating to obesity, diabetes, and cardiovascular disease. JAMA 287:2414–2423PubMedCrossRef
41.
go back to reference Kallio P, Kolehmainen M, Laaksonen DE et al (2008) Inflammation markers are modulated by responses to diets differing in postprandial insulin responses in individuals with the metabolic syndrome. Am J Clin Nutr 87:1497–1503PubMed Kallio P, Kolehmainen M, Laaksonen DE et al (2008) Inflammation markers are modulated by responses to diets differing in postprandial insulin responses in individuals with the metabolic syndrome. Am J Clin Nutr 87:1497–1503PubMed
42.
go back to reference de Mello VD, Kolehmainen M, Schwab U et al (2008) Effect of weight loss on cytokine messenger RNA expression in peripheral blood mononuclear cells of obese subjects with the metabolic syndrome. Metabolism 57:192–199PubMedCrossRef de Mello VD, Kolehmainen M, Schwab U et al (2008) Effect of weight loss on cytokine messenger RNA expression in peripheral blood mononuclear cells of obese subjects with the metabolic syndrome. Metabolism 57:192–199PubMedCrossRef
43.
go back to reference Herder C, Peltonen M, Koenig W et al (2009) Anti-inflammatory effect of lifestyle changes in the Finnish Diabetes Prevention Study. Diabetologia 52:433–442PubMedCrossRef Herder C, Peltonen M, Koenig W et al (2009) Anti-inflammatory effect of lifestyle changes in the Finnish Diabetes Prevention Study. Diabetologia 52:433–442PubMedCrossRef
44.
go back to reference Petersson H, Lind L, Hulthe J, Elmgren A, Cederholm T, Riserus U (2009) Relationships between serum fatty acid composition and multiple markers of inflammation and endothelial function in an elderly population. Atherosclerosis 203:298–303PubMedCrossRef Petersson H, Lind L, Hulthe J, Elmgren A, Cederholm T, Riserus U (2009) Relationships between serum fatty acid composition and multiple markers of inflammation and endothelial function in an elderly population. Atherosclerosis 203:298–303PubMedCrossRef
45.
go back to reference Festa A, Hanley AJ, Tracy RP, D'Agostino R Jr, Haffner SM (2003) Inflammation in the prediabetic state is related to increased insulin resistance rather than decreased insulin secretion. Circulation 108:1822–1830PubMedCrossRef Festa A, Hanley AJ, Tracy RP, D'Agostino R Jr, Haffner SM (2003) Inflammation in the prediabetic state is related to increased insulin resistance rather than decreased insulin secretion. Circulation 108:1822–1830PubMedCrossRef
46.
go back to reference Lakka HM, Laaksonen DE, Lakka TA et al (2002) The metabolic syndrome and total and cardiovascular disease mortality in middle-aged men. JAMA 288:2709–2716PubMedCrossRef Lakka HM, Laaksonen DE, Lakka TA et al (2002) The metabolic syndrome and total and cardiovascular disease mortality in middle-aged men. JAMA 288:2709–2716PubMedCrossRef
47.
go back to reference Meigs JB (2010) Epidemiology of type 2 diabetes and cardiovascular disease: translation from population to prevention: the Kelly West award lecture 2009. Diabetes Care 33:1865–1871PubMedCrossRef Meigs JB (2010) Epidemiology of type 2 diabetes and cardiovascular disease: translation from population to prevention: the Kelly West award lecture 2009. Diabetes Care 33:1865–1871PubMedCrossRef
48.
go back to reference Bonetti PO, Lerman LO, Lerman A (2003) Endothelial dysfunction: a marker of atherosclerotic risk. Arterioscler Thromb Vasc Biol 23:168–175PubMedCrossRef Bonetti PO, Lerman LO, Lerman A (2003) Endothelial dysfunction: a marker of atherosclerotic risk. Arterioscler Thromb Vasc Biol 23:168–175PubMedCrossRef
49.
go back to reference Jenkins DJ, Kendall CW, Marchie A et al (2003) Effects of a dietary portfolio of cholesterol-lowering foods vs lovastatin on serum lipids and C-reactive protein. JAMA 290:502–510PubMedCrossRef Jenkins DJ, Kendall CW, Marchie A et al (2003) Effects of a dietary portfolio of cholesterol-lowering foods vs lovastatin on serum lipids and C-reactive protein. JAMA 290:502–510PubMedCrossRef
50.
go back to reference Haas MJ, Mooradian AD (2011) Inflammation, high-density lipoprotein and cardiovascular dysfunction. Curr Opin Infect Dis 24:265–272PubMedCrossRef Haas MJ, Mooradian AD (2011) Inflammation, high-density lipoprotein and cardiovascular dysfunction. Curr Opin Infect Dis 24:265–272PubMedCrossRef
51.
go back to reference Matsuda M, DeFronzo RA (1999) Insulin sensitivity indices obtained from oral glucose tolerance testing: comparison with the euglycemic insulin clamp. Diabetes Care 22:1462–1470PubMedCrossRef Matsuda M, DeFronzo RA (1999) Insulin sensitivity indices obtained from oral glucose tolerance testing: comparison with the euglycemic insulin clamp. Diabetes Care 22:1462–1470PubMedCrossRef
Metadata
Title
A diet high in fatty fish, bilberries and wholegrain products improves markers of endothelial function and inflammation in individuals with impaired glucose metabolism in a randomised controlled trial: The Sysdimet study
Authors
V. D. F. de Mello
U. Schwab
M. Kolehmainen
W. Koenig
M. Siloaho
K. Poutanen
H. Mykkänen
M. Uusitupa
Publication date
01-11-2011
Publisher
Springer-Verlag
Published in
Diabetologia / Issue 11/2011
Print ISSN: 0012-186X
Electronic ISSN: 1432-0428
DOI
https://doi.org/10.1007/s00125-011-2285-3

Other articles of this Issue 11/2011

Diabetologia 11/2011 Go to the issue
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discuss last year's major advances in heart failure and cardiomyopathies.